News + Filings Holdings
All
13F
13D/G
Other
|
|
PFM Health Sciences, LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 1.8% stake in IO Biotech, Inc. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 4.9% stake in Generation Bio Co. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 0.7% stake in Jounce Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 0% stake in Outset Medical, Inc. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 3% stake in Adaptimmune Therapeutics PLC |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 5.9% stake in Praxis Precision Medicines, Inc. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 3.7% stake in Arcus Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 4.9% stake in uniQure N.V. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 7.3% stake in Caribou Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 3.2% stake in Axsome Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 8.7% stake in ESSA Pharma Inc. |
| 01/17/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| PFM Health Sciences, LP reports a 2.3% stake in Aerie Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| PFM Health Sciences, LP reports a 6.2% stake in Outset Medical, Inc. |
| 02/14/2022 |
SC 13G/A
| PFM Health Sciences, LP reports a 4.9% stake in Arcus Biosciences, Inc. |
| 02/14/2022 |
SC 13G/A
| PFM Health Sciences, LP reports a 7.8% stake in Jounce Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| PFM Health Sciences, LP reports a 6.8% stake in Caribou Biosciences, Inc. |
| 02/16/2021 |
SC 13G/A
| PFM Health Sciences, LP reports a 0% stake in Dermira, Inc. |
| 02/16/2021 |
SC 13G/A
| PFM Health Sciences, LP reports a 6.8% stake in Outset Medical, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Partner Fund Management, L.P. reports a 0% stake in Equillium, Inc. |
| 02/14/2020 |
SC 13G/A
| Partner Fund Management, L.P. reports a 0% stake in Neon Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| Partner Fund Management, L.P. reports a 0% stake in Aptinyx Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Partner Fund Management, L.P. reports a 0% stake in Esperion Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Partner Fund Management, L.P. reports a 2.7% stake in Audentes Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Partner Fund Management, L.P. reports a 0% stake in Voyager Therapeutics, Inc. |
|
|
|